GROVE COLLABORATIVE HOLDINGS INC

Insider Trading & Executive Data

GROV
NYSE
Consumer Defensive
Household & Personal Products

Start Free Trial

Get the full insider signal for GROV

177 insider trades in the last year. Go beyond summary counts with transaction-level detail, compensation intelligence, and institutional ownership context.

Trade-level insider transactions with filing links, transaction codes, and footnotes
Executive compensation trends by role with year-over-year comparisons
Institutional ownership shifts by quarter with top-holder concentration data
Form 144 and Form 8-K monitoring with AI analysis and CSV export tools

Insider Activity Summary

Insider Trades (1Y)
177
33 in last 30 days
Buy / Sell (1Y)
78/99
Acquisitions / Dispositions
Unique Insiders (1Y)
8
Active in past year
Insider Positions
29
Current holdings
Position Status
24/5
Active / Exited
Institutional Holders
30
Latest quarter
Board Members
0

Compensation & Governance

Avg Total Compensation
$3.2M
Latest year: 2024
Executives Covered
5
Comp records available
Form 8-K Events (1Y)
2
Personnel Changes (1Y)
2
Bonus Plan Events (1Y)
0
Organization Changes (1Y)
0
Board Appointments (1Y)
2
Board Departures (1Y)
1

Restricted Sales

Form 144 Filings (1Y)
0
Form 144 Insiders (1Y)
0
Planned Sale Shares (1Y)
0
Planned Sale Value (1Y)
$0.00
Price
$1.43
Market Cap
$60.4M
Volume
2,140
EPS
$-0.08
Revenue
$43.7M
Employees
415
About GROVE COLLABORATIVE HOLDINGS INC

Company Overview

Grove Collaborative (GROV) is a California‑based, sustainability‑focused DTC retailer in the Consumer Defensive sector and Household & Personal Products industry that develops its own Grove Brands and curates ~300 third‑party natural and mission‑driven brands across home care, beauty, personal care, wellness and paper products. In 2024 Grove Brands accounted for ~41% of net revenue, the platform served ~688k customers, and the company operates two fulfillment centers capable of 2‑day reach to ~80% of customers. Management has pivoted from growth‑at‑all‑costs toward profitability by materially cutting advertising and headcount, which narrowed operating losses and produced positive Adjusted EBITDA but drove revenue declines and left an accumulated deficit (~$648.5M) and constrained liquidity. Key operational and regulatory exposures include CAC and subscription cadence, fulfillment and freight costs, supply‑chain audits, and oversight by FDA/CPSC/EPA/FTC and evolving privacy laws.

Executive Compensation Practices

Compensation at Grove is likely to combine modest cash pay with material equity and performance‑linked incentives common in Retail/DTC CPGs, but the company’s recent cost cuts have reduced cash pay pressure and stock‑based compensation has become a more meaningful retention tool. Given management commentary and MD&A metrics, executives’ bonuses and performance awards are likely tied to Adjusted EBITDA or cash‑flow improvement, gross margin expansion, active DTC customers/subscribe‑and‑save retention, and customer acquisition efficiency (CAC/LTV). As a public benefit corporation and Certified B Corp, Grove may also incorporate mission‑related KPIs (sustainability targets like Beyond Plastic™, ingredient standards, and carbon‑neutral shipping) into long‑term incentives. Liquidity constraints, outstanding warrants/earnouts and frequent preferred financings make equity dilution and valuation‑sensitive accounting (stock‑based comp, derivative liabilities) important factors shaping award design and vesting schedules to preserve cash and limit near‑term dilution.

Insider Trading Considerations

Insider trading at Grove will likely be influenced by discrete operational catalysts—Shopify migration milestones, quarterly results tied to advertising and subscription cadence, completion of the brick‑and‑mortar exit, and financing events (SEPA/preferred financings, revolver amendments)—all of which can rapidly change liquidity and valuation expectations. Because the company has limited unrestricted cash and has used preferred equity and derivative instruments, insiders may transact for liquidity (option exercises, tax needs) rather than signaling lack of confidence; monitor timing, use of 10b5‑1 plans, and cluster sales that coincide with financings. Regulatory developments affecting product claims or advertising (FDA/FTC/EPA rulings or MOCRA changes) and the NYSE listing cure status are also material catalysts that could precede insider trades. For traders and researchers, pay attention to patterns around earnings releases, platform‑migration updates, and financing announcements rather than treating isolated sales as purely negative signals.

Unlock Full Insider Trading Data
Get complete access to insider trades, executive compensation, institutional holdings, and AI-powered analysis for GROVE COLLABORATIVE HOLDINGS INC and thousands of other companies.
Individual insider trade details with transaction history
Executive compensation breakdown by position
Institutional holder analysis with quarterly comparisons
Insider holdings with temporal change tracking
Form 144 restricted sale filings with details
Form 8-K governance events and personnel changes
10b5-1 trading plan analysis
AI-powered insights and conversational analysis
Board of directors profiles and governance data
Advanced filtering, sorting, and CSV export
No credit card required
Cancel anytime